Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Asmaa Gomaa(Imperial College London), Shahid A. Khan(Engineering and Physical Sciences Research Council), Mireille B. Toledano(University of British Columbia), Imam Waked(GlaxoSmithKline (United Kingdom)), Simon D. Taylor‐Robinson(Pfizer (United Kingdom))
World Journal of Gastroenterology
January 1, 2008
Cited by 698Open Access
Full Text

Abstract

Hepatocellular carcinoma (HCC) is the commonest primary malignant cancer of the liver in the world. Given that the burden of chronic liver disease is expected to rise owing to increasing rates of alcoholism, hepatitis B and C prevalence and obesity-related fatty liver disease, it is expected that the incidence of HCC will also increase in the foreseeable future. This article summarizes the international epidemiology, the risk factors and the pathogenesis of HCC, including the roles of viral hepatitis, toxins, such as alcohol and aflatoxin, and insulin resistance.


Related Papers

No related papers found

Powered by citation graph analysis